Last reviewed · How we verify
NCT04131140
Organ Donation and End-of-life Decisions
trial in Decision Making in 12,072 participants. Completed in 22 March 2018.
31 December 2017
Quick facts
| Lead sponsor | Swedish Intensive Care Registry |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 12,072 |
| Start date | 1 January 2014 |
| Primary completion | 31 December 2017 |
| Estimated completion | 22 March 2018 |
| Sites | 1 location across Sweden |
Conditions studied
- Decision Making — all drugs for Decision Making →
- Terminal Illness — all drugs for Terminal Illness →
- Tissue and Organ Procurement — all drugs for Tissue and Organ Procurement →
Sponsor
Swedish Intensive Care Registry
Who can join
Eligibility, any sex, with Decision Making or Terminal Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Variation in organ donation after brain death (DBD) per million population varies markedly between countries, within country regions, between and within intensive care units (ICU). These circumstances also apply to end-of-life decisions in the ICU. The investigators studied all ICU deaths in Sweden between 2014-2017 in ICUs that, as routine, registered treatment plan (no treatment limitation and/or treatment limitation) and DBD. The investigators hypothesized that ICUs with high proportion of treatment limitation (withholding or withdrawing life sustaining treatment) also had less proportion of DBD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04131140
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Decision Making
Currently open trials in the same condition.
- NCT06375551 — K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions · NA · recruiting
- NCT06852170 — Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev · NA · recruiting
- NCT06735417 — Impacts of the Indashyikirwa Program on Intimate Partner Violence in Syria · NA · active not recruiting
- NCT06731361 — Improved Prescribing for Older Nursing Home Patients · NA · recruiting
- NCT06638554 — Integrating Telehealth to Advance Lung Cancer Screening · NA · recruiting
Other Swedish Intensive Care Registry trials
Trials by the same sponsor.
- NCT06042790 — Patients´ Mental and Physical Health After Covid-19 Treated in ICU in Sweden · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04131140 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Swedish Intensive Care Registry
- Last refreshed: 18 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04131140.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing